...
首页> 外文期刊>Journal of Internal Medicine >Profiling of immune‐related gene expression in children with familial hypercholesterolaemia
【24h】

Profiling of immune‐related gene expression in children with familial hypercholesterolaemia

机译:家族性高胆固醇血症儿童免疫相关基因表达的分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Background Innate and adaptive immune responses are pivotal in atherosclerosis, but their association with early‐stage atherosclerosis in humans is incompletely understood. In this regard, untreated children with familial hypercholesterolaemia may serve as a human model to investigate the effect of elevated low‐density lipoprotein (LDL)‐cholesterol. Objectives We aimed to study the immunological and inflammatory pathways involved in early atherosclerosis by examining mRNA molecules in peripheral blood mononuclear cells (PBMCs) from children with FH. Methods We analysed the level of 587 immune‐related mRNA molecules using state‐of‐the‐art Nanostring technology in PBMCs from children with ( n ?=?30) and without ( n ?=?21) FH, and from FH children before and after statin therapy ( n ?=?10). Results 176 genes (30%) were differentially expressed between the FH and healthy children at P ??0.05. Compared to healthy children, the dysregulated pathways in FH children included the following: T cells (18/19); B cells (5/6); tumour necrosis factor super family (TNFSF) (6/8); cell growth, proliferation and differentiation (5/7); interleukins (5/9); toll‐like receptors (2/5); apoptosis (3/7) and antigen presentation (1/7), where the ratio denotes higher expressed genes to total number of genes. Statin therapy reversed expression of thirteen of these mRNAs in FH children. Conclusion FH children display higher PBMC expression of immune‐related genes mapped to several pathways, including T and B cells, and TNFSF than healthy children. Our results suggest that LDL‐C plays an important role in modulating expression of different immune‐related genes, and novel data on the involvement of these pathways in the early atherosclerosis may represent future therapeutic targets for prevention of atherosclerotic progression.
机译:摘要背景存在于动脉粥样硬化中的先天性和适应性免疫应答,但它们与人类早期动脉粥样硬化的关联不完全理解。在这方面,具有家族性高胆固醇的未经处理的儿童可以作为人体模型,以研究升高的低密度脂蛋白(LDL) - 碳酸酯的影响。目标我们旨在研究早期动脉粥样硬化的免疫和炎症途径,通过从FH的儿童检查外周血单核细胞(PBMC)中的mRNA分子。方法使用(n?= 30)的儿童,在PBMC中分析了使用最先进的纳米型技术的587个免疫相关mRNA分子水平的水平,没有(n?=?21)fh,以及之前的FH儿童和他汀类药物治疗后(n?=?10)。结果176个基因(30%)在P = 0.05的FH和健康儿童之间差异表达。与健康儿童相比,FH儿童中的失调途径包括以下:T细胞(18/19); B细胞(5/6);肿瘤坏死因子超级家庭(TNFSF)(6/8);细胞生长,增殖和分化(5/7);白细胞介素(5/9);含量的受体(2/5);细胞凋亡(3/7)和抗原呈递(1/7),其中比率表示较高表达基因到基因的总数。他汀类药物治疗在FH儿童中逆转了十三个这些MRNA的表达。结论FH儿童显示较高的免疫相关基因的PBMC表达,映射到几种途径,包括T和B细胞,以及TNFSF而不是健康儿童。我们的研究结果表明,LDL-C在调节不同免疫相关基因的表达方面发挥着重要作用,以及关于这些途径在早期动脉粥样硬化中的涉及的新数据可能代表未来治疗预防动脉粥样硬化进展的治疗靶标。

著录项

  • 来源
    《Journal of Internal Medicine》 |2020年第3期|共12页
  • 作者单位

    Norwegian National Advisory Unit on Familial HypercholesterolemiaOslo University HospitalOslo Norway;

    Norwegian National Advisory Unit on Familial HypercholesterolemiaOslo University HospitalOslo Norway;

    Center of Molecular Inflammation ResearchNorwegian University of Science and TechnologyTrondheim;

    Department of NutritionUniversity of OsloOslo Norway;

    Department of NutritionUniversity of OsloOslo Norway;

    Research Institute for Internal MedicineOslo University HospitalOslo Norway;

    Center of Molecular Inflammation ResearchNorwegian University of Science and TechnologyTrondheim;

    Norwegian National Advisory Unit on Familial HypercholesterolemiaOslo University HospitalOslo Norway;

    Department of NutritionUniversity of OsloOslo Norway;

    Research Institute for Internal MedicineOslo University HospitalOslo Norway;

    Research Institute for Internal MedicineOslo University HospitalOslo Norway;

    Norwegian National Advisory Unit on Familial HypercholesterolemiaOslo University HospitalOslo Norway;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内科学;
  • 关键词

    familial hypercholesterolaemia; children; gene expression; inflammation; statins;

    机译:家族性高胆固醇血症;儿童;基因表达;炎症;他汀类药物;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号